Following these proceedings, A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in late March has reiterated a ‘”a Buy”‘ rating for it. TD Securities also remained covering FNV and has decreased its forecast on March 11, 2025 with a “Hold” recommendation from previously “Buy” rating. Canaccord Genuity revised its rating on November 18, 2024. It rated FNV as “a Buy” which previously was an “a Hold”.
Price Performance Review of FNV
On Monday, Franco-Nevada Corporation [NYSE:FNV] saw its stock jump 1.22% to $173.18. Over the last five days, the stock has gained 4.17%. Franco-Nevada Corporation shares have risen nearly 47.27% since the year began. Nevertheless, the stocks have risen 43.75% over the past one year. While a 52-week high of $174.44 was reached on 04/21/25, a 52-week low of $112.70 was recorded on 01/02/25. SMA at 50 days reached $150.36, while 200 days put it at $131.18.
Levels Of Support And Resistance For FNV Stock
The 24-hour chart illustrates a support level at 169.66, which if violated will result in even more drops to 166.13. On the upside, there is a resistance level at 177.72. A further resistance level may holdings at 182.26. The Relative Strength Index (RSI) on the 14-day chart is 70.64, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 12.58, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 14.36%. Stochastics %K at 88.72% indicates the stock is a selling.
How much short interest is there in Franco-Nevada Corporation?
A steep rise in short interest was recorded in Franco-Nevada Corporation stocks on 2025-03-31, growing by 0.74 million shares to a total of 2.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 2.05 million shares. There was a rise of 26.54%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 18, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $160 price target.
